Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.

CONCLUSIONS: The integration of imaging and TB features drastically improves the intermediate risk sub-classification performance and better discriminates the unfavourable risk group that could benefit from more aggressive therapy such as neo-adjuvant and/or adjuvant treatment, and the favourable group that could avoid over-treatment. External validation in other datasets is needed.
PMID: 31948932 [PubMed - as supplied by publisher]

Source: Urologic Oncology - January 12, 2020 Category: Urology & Nephrology Authors: Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G Tags: Urol Oncol Source Type: research